nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Analysis of respiratory mechanics in animal models: Its use in understanding lung behavior in emphysema and asthma
|
Biselli, Paolo José Cesare |
|
|
|
C |
p. 11-17 |
artikel |
2 |
Animal and cell models for Lesch-Nyhan syndrome
|
Micheli, Vanna |
|
|
|
C |
p. 45-57 |
artikel |
3 |
Animal models for heart valve research and development
|
Kheradvar, Arash |
|
2017 |
|
C |
p. 55-62 |
artikel |
4 |
Animal Models for Microbiome Research and Drug Discovery
|
Richter, Philip J. |
|
|
|
C |
p. 1-2 |
artikel |
5 |
Animal models for understanding microbial decomposition of human remains
|
Belk, Aeriel D. |
|
|
|
C |
p. 117-125 |
artikel |
6 |
Animal models in bone repair
|
von Rechenberg, Brigitte |
|
2014 |
|
C |
p. 23-27 5 p. |
artikel |
7 |
Animal models of bone disease and repair
|
Hoffmann, Oskar |
|
2014 |
|
C |
p. 1-2 2 p. |
artikel |
8 |
Animal models of cardiovascular disease as test beds of bioengineered vascular grafts
|
Row, Sindhu |
|
2017 |
|
C |
p. 37-45 |
artikel |
9 |
Animal models of kidney inflammation in translational medicine
|
Holderied, Alexander |
|
2014 |
|
C |
p. 19-27 9 p. |
artikel |
10 |
Animal models of regression/progression of kidney disease
|
Lim, Beom Jin |
|
2014 |
|
C |
p. 45-51 7 p. |
artikel |
11 |
Animal models of renal disease
|
Alpers, Charles E. |
|
2014 |
|
C |
p. 1-4 4 p. |
artikel |
12 |
Animal models of vascular stenting
|
Perkins, Laura E. Leigh |
|
2017 |
|
C |
p. 31-36 |
artikel |
13 |
An Opinion on non-human primates testing in Europe
|
Epstein, Michelle M. |
|
2017 |
|
C |
p. 5-9 |
artikel |
14 |
Ant microbial symbionts are a new model for drug discovery
|
Artavia-León, Allan |
|
|
|
C |
p. 27-33 |
artikel |
15 |
Applicability of epithelial models in protein permeability/transport studies and food allergy
|
Cubells-Baeza, N. |
|
2015 |
|
C |
p. 13-21 9 p. |
artikel |
16 |
Applying the 3Rs to non-human primate research: Barriers and solutions
|
Prescott, Mark J. |
|
2017 |
|
C |
p. 51-56 |
artikel |
17 |
A primer on ageing studies in mice: Considerations, opportunities and limitations
|
Potter, Paul K. |
|
2018 |
|
C |
p. 23-29 |
artikel |
18 |
A review of animal models used to evaluate potential allergenicity of genetically modified organisms (GMOs)
|
Marsteller, Nathan |
|
2015 |
|
C |
p. 81-88 8 p. |
artikel |
19 |
A review of mathematical models for leukemia and lymphoma
|
Clapp, Geoffrey |
|
2015 |
|
C |
p. 1-6 6 p. |
artikel |
20 |
Assessing interindividual variability by Bayesian-PBPK modeling
|
Krauss, Markus |
|
2016 |
|
C |
p. 15-19 |
artikel |
21 |
Atlas-based anatomical modeling and analysis of heart disease
|
Medrano-Gracia, Pau |
|
2014 |
|
C |
p. 33-39 7 p. |
artikel |
22 |
Bone pathology in murine models of inflammatory arthritis
|
Zwerina, Jochen |
|
2014 |
|
C |
p. 11-15 5 p. |
artikel |
23 |
Budding yeast as a model to study epigenetics
|
Fuchs, Stephen M. |
|
2014 |
|
C |
p. 1-6 6 p. |
artikel |
24 |
Cancer gene therapy: innovations in therapeutic delivery of CRISPR-Cas9
|
Lindsay-Mosher, Nicole |
|
2016 |
|
C |
p. 17-21 5 p. |
artikel |
25 |
Capturing intracellular Ca2+ dynamics in computational models of neurodegenerative diseases
|
Anwar, Haroon |
|
2016 |
|
C |
p. 37-42 6 p. |
artikel |
26 |
C. elegans and its bacterial diet: An interspecies model to explore the effects of microbiota on drug response
|
Diot, Cédric |
|
|
|
C |
p. 21-26 |
artikel |
27 |
Cell and tissue models of alkaptonuria
|
Braconi, Daniela |
|
|
|
C |
p. 3-10 |
artikel |
28 |
Chediak-Higashi syndrome: A review of the past, present, and future
|
Sharma, Prashant |
|
|
|
C |
p. 31-36 |
artikel |
29 |
Computational approaches for the systematic analysis of aging-associated molecular alterations
|
Debès, Cédric |
|
2018 |
|
C |
p. 51-59 |
artikel |
30 |
Computational Drug Networks: a computational approach to elucidate drug mode of action and to facilitate drug repositioning for neurodegenerative diseases
|
Sirci, Francesco |
|
2016 |
|
C |
p. 11-17 7 p. |
artikel |
31 |
Computational modeling helps uncover mechanisms related to the progression of emphysema
|
Suki, Béla |
|
2015 |
|
C |
p. 9-15 7 p. |
artikel |
32 |
Computational modeling to advance deep brain stimulation for the treatment of Parkinson’s disease
|
Holt, Abbey B. |
|
2016 |
|
C |
p. 31-36 6 p. |
artikel |
33 |
Computational modeling to improve treatments for essential tremor
|
Lee, Shane |
|
2016 |
|
C |
p. 19-25 7 p. |
artikel |
34 |
Computational modelling of Hedgehog signalling in liver regeneration
|
Matz-Soja, Madlen |
|
2016 |
|
C |
p. 45-50 |
artikel |
35 |
Computational models for patient-specific analysis of pulmonary vascular disease
|
Clark, Alys |
|
2015 |
|
C |
p. 29-36 8 p. |
artikel |
36 |
Computational models for predictive cardiac ion channel pharmacology
|
Yarov-Yarovoy, Vladimir |
|
2014 |
|
C |
p. 3-10 8 p. |
artikel |
37 |
Computational models of heart disease
|
Smith, Nic |
|
2014 |
|
C |
p. 1-2 2 p. |
artikel |
38 |
Computational models of lung diseases
|
Tawhai, Merryn H. |
|
2015 |
|
C |
p. 1-2 2 p. |
artikel |
39 |
Computational models of ventilator induced lung injury and surfactant dysfunction
|
Bates, Jason H.T. |
|
2015 |
|
C |
p. 17-22 6 p. |
artikel |
40 |
Computational models of ventricular arrhythmia mechanisms: recent developments and future prospects
|
Clayton, R.H. |
|
2014 |
|
C |
p. 17-22 6 p. |
artikel |
41 |
Computer modeling for pharmacological treatments for dystonia
|
Neymotin, Samuel A. |
|
2016 |
|
C |
p. 51-57 7 p. |
artikel |
42 |
Computer modeling of epilepsy: opportunities for drug discovery
|
Lytton, William W. |
|
2016 |
|
C |
p. 27-30 4 p. |
artikel |
43 |
Computer modeling of ischemic stroke
|
Newton, Adam J.H. |
|
2016 |
|
C |
p. 77-83 7 p. |
artikel |
44 |
Contents
|
|
|
2014 |
|
C |
p. i- 1 p. |
artikel |
45 |
Contents
|
|
|
2014 |
|
C |
p. i- 1 p. |
artikel |
46 |
Contents
|
|
|
2014 |
|
C |
p. i- 1 p. |
artikel |
47 |
Contents
|
|
|
2015 |
|
C |
p. i- 1 p. |
artikel |
48 |
Contents
|
|
|
2015 |
|
C |
p. i- 1 p. |
artikel |
49 |
Contents
|
|
|
2014 |
|
C |
p. i- 1 p. |
artikel |
50 |
Contents page
|
|
|
2015 |
|
C |
p. i- 1 p. |
artikel |
51 |
Contents page
|
|
|
2016 |
|
C |
p. i- 1 p. |
artikel |
52 |
Cuprizone as a model of myelin and axonal damage
|
Nyamoya, Stella |
|
2017 |
|
C |
p. 63-68 |
artikel |
53 |
Current technological advances in mapping new DNA modifications
|
Amouroux, Rachel |
|
2014 |
|
C |
p. 15-26 12 p. |
artikel |
54 |
Developing genetically engineered mouse models using engineered nucleases: Current status, challenges, and the way forward
|
Lee, Jaehoon |
|
2016 |
|
C |
p. 13-20 8 p. |
artikel |
55 |
Development of animal models of human IgA nephropathy
|
Suzuki, Hitoshi |
|
2014 |
|
C |
p. 5-11 7 p. |
artikel |
56 |
Development of quantitative systems pharmacology and toxicology models within consortia: experiences and lessons learned through DILIsym development
|
Howell, Brett A. |
|
2016 |
|
C |
p. 5-13 |
artikel |
57 |
Diaphragm muscle adaptations in health and disease
|
Fogarty, Matthew J. |
|
|
|
C |
p. 43-52 |
artikel |
58 |
Disease models in cerebral cavernous malformations
|
Glading, Angela J. |
|
|
|
C |
p. 21-29 |
artikel |
59 |
Disorders of complement regulation
|
Barbour, Thomas D. |
|
2014 |
|
C |
p. 29-35 7 p. |
artikel |
60 |
Drosophila and its gut microbes: A model for drug-microbiome interactions
|
Douglas, Angela E. |
|
|
|
C |
p. 43-49 |
artikel |
61 |
Editorial and introduction by Kitty Verhoeckx, Liam O’Mahony and Michelle M. Epstein
|
|
|
2015 |
|
C |
p. 1-2 2 p. |
artikel |
62 |
Editorial DDT: Cancer models in drug development
|
Mader, Robert M. |
|
2016 |
|
C |
p. 1-2 2 p. |
artikel |
63 |
Editorial: Models for Aging Research
|
Mack, Hildegard |
|
2018 |
|
C |
p. 1-2 |
artikel |
64 |
Editorial to “Computational models of liver disease 2016”
|
Henney, Adriano M. |
|
2016 |
|
C |
p. 1-3 |
artikel |
65 |
Editorial to “Evaluating biomaterials and implanted devices”
|
Gaetani, Roberto |
|
2017 |
|
C |
p. 1-3 |
artikel |
66 |
Editorial to “Lung mechanics”
|
Klein, Wilfried |
|
|
|
C |
p. 1-2 |
artikel |
67 |
Editorial to “Novel development in mouse phenotyping 2014”
|
Brown, Steve |
|
2016 |
|
C |
p. 1-2 2 p. |
artikel |
68 |
Editorial to “Use of non-human primate disease models”
|
Vermeire, Theo |
|
2017 |
|
C |
p. 1-3 |
artikel |
69 |
Epithelial models to study food allergen-induced barrier disruption and immune activation
|
Gavrovic-Jankulovic, Marija |
|
2015 |
|
C |
p. 29-36 8 p. |
artikel |
70 |
Evolution of cancer cell resistance versus intelligent design of epigenetic drugs
|
Barbieri, Isaia |
|
2014 |
|
C |
p. 35-39 5 p. |
artikel |
71 |
Experimental food allergy models to study the role of innate immune cells as initiators of allergen-specific Th2 immune responses
|
Hussain, Maryam |
|
2015 |
|
C |
p. 55-62 8 p. |
artikel |
72 |
Experimental models of cortical multiple sclerosis pathology
|
Witte, Maarten E. |
|
2017 |
|
C |
p. 69-74 |
artikel |
73 |
Extracellular matrix components remodeling and lung function parameters in experimental emphysema and allergic asthma: Differences among the mouse strains
|
Oliveira, Milena Vasconcellos |
|
|
|
C |
p. 27-34 |
artikel |
74 |
Fish: a suitable system to model human bone disorders and discover drugs with osteogenic or osteotoxic activities
|
Laizé, Vincent |
|
2014 |
|
C |
p. 29-37 9 p. |
artikel |
75 |
Genome wide conditional mouse knockout resources
|
Kaloff, C. |
|
2016 |
|
C |
p. 3-12 10 p. |
artikel |
76 |
Gut microbes as a therapeutic armory
|
Bhardwaj, Neerupma |
|
|
|
C |
p. 51-59 |
artikel |
77 |
Honey bee as a model organism to study gut microbiota and diseases
|
Wang, Xiaofei |
|
|
|
C |
p. 35-42 |
artikel |
78 |
Humanized mouse model for evaluating biocompatibility and human immune cell interactions to biomaterials
|
Wang, Raymond M. |
|
2017 |
|
C |
p. 23-29 |
artikel |
79 |
Human neurons to model aging: A dish best served old
|
Böhnke, Lena |
|
2018 |
|
C |
p. 43-49 |
artikel |
80 |
IgE – the main player of food allergy
|
Broekman, Henrike C.H. |
|
2015 |
|
C |
p. 37-44 8 p. |
artikel |
81 |
Impact of senescence on bone quality: lessons from animal models of aging
|
Richards, Peter J. |
|
2014 |
|
C |
p. 17-22 6 p. |
artikel |
82 |
Influence of microbiome and diet on immune responses in food allergy models
|
Barcik, Weronika |
|
2015 |
|
C |
p. 71-80 10 p. |
artikel |
83 |
Innovative in vitro models for breast cancer drug discovery
|
Kaemmerer, Elke |
|
2016 |
|
C |
p. 11-16 6 p. |
artikel |
84 |
In silico modeling of malaria and sickle-cell disease
|
Fedosov, Dmitry A. |
|
2015 |
|
C |
p. 17-22 6 p. |
artikel |
85 |
In silico models of M. tuberculosis infection provide a route to new therapies
|
Linderman, Jennifer J. |
|
2015 |
|
C |
p. 37-41 5 p. |
artikel |
86 |
In silico tools for exploring potential human allergy to proteins
|
Hayes, Maria |
|
2015 |
|
C |
p. 3-11 9 p. |
artikel |
87 |
Interactions between human microbiome, diet, enteric viruses and immune system: Novel insights from gnotobiotic pig research
|
Vlasova, Anastasia N. |
|
|
|
C |
p. 95-103 |
artikel |
88 |
Interstitial lung disease and surfactant dysfunction as a secondary manifestation of disease: insights from lysosomal storage disorders
|
Paget, Tamara L. |
|
|
|
C |
p. 35-42 |
artikel |
89 |
In vitro and in vivo models for assessing the host response to biomaterials
|
Saleh, Leila S. |
|
2017 |
|
C |
p. 13-21 |
artikel |
90 |
Ischemic heart disease and coronary flow
|
Kassab, Ghassan S. |
|
2014 |
|
C |
p. 41-47 7 p. |
artikel |
91 |
Large animal models to test mechanical circulatory support devices
|
Miyamoto, Takuma |
|
2017 |
|
C |
p. 47-53 |
artikel |
92 |
Lupus nephritis: animal modeling of a complex disease syndrome pathology
|
McGaha, Tracy L. |
|
2014 |
|
C |
p. 13-18 6 p. |
artikel |
93 |
Mass spectrometry analysis of histone post translational modifications
|
Minshull, Thomas C. |
|
2014 |
|
C |
p. 41-48 8 p. |
artikel |
94 |
Mathematical modeling of ventilation defects in asthma
|
Winkler, Tilo |
|
2015 |
|
C |
p. 3-8 6 p. |
artikel |
95 |
Measles: What we have learned from non-human primate models
|
de Swart, Rik L. |
|
2017 |
|
C |
p. 31-34 |
artikel |
96 |
Modeling approaches for hepatic spatial heterogeneity in pharmacokinetic simulations
|
Schwen, Lars Ole |
|
2016 |
|
C |
p. 35-43 |
artikel |
97 |
Modeling cytokine regulatory network dynamics driving neuroinflammation in central nervous system disorders
|
Anderson, Warren D. |
|
2016 |
|
C |
p. 59-67 9 p. |
artikel |
98 |
Modeling neurological disease processes using process algebra
|
Anastasio, Thomas J. |
|
2016 |
|
C |
p. 43-49 7 p. |
artikel |
99 |
Modelling ageing and age-related disease
|
Bellantuono, Ilaria |
|
2016 |
|
C |
p. 27-32 6 p. |
artikel |
100 |
Modelling amyotrophic lateral sclerosis in mice
|
Stephenson, Jodie |
|
2017 |
|
C |
p. 35-44 |
artikel |
101 |
Modelling in miniature: Using Drosophila melanogaster to study human neurodegeneration
|
Lambrechts, Roald |
|
2017 |
|
C |
p. 3-10 |
artikel |
102 |
Models for evaluating the immune response to naturally derived biomaterials
|
Dziki, Jenna L. |
|
2017 |
|
C |
p. 5-11 |
artikel |
103 |
Models of neuroimmune and neurodegenerative diseases
|
Amor, Sandra |
|
2017 |
|
C |
p. 1-2 |
artikel |
104 |
Models of rare diseases
|
Braconi, Daniela |
|
|
|
C |
p. 1-2 |
artikel |
105 |
Model systems for the study of how symbiotic associations between animals and extracellular bacterial partners are established and maintained
|
Koch, Eric J. |
|
|
|
C |
p. 3-12 |
artikel |
106 |
Mouse models of central nervous system ageing
|
Heng, Yang |
|
2017 |
|
C |
p. 21-34 |
artikel |
107 |
Multi-scale biological and physical modelling of the tumour micro-environment
|
Kunz, Robert F. |
|
2015 |
|
C |
p. 7-15 9 p. |
artikel |
108 |
Multiscale modeling for drug discovery in brain disease
|
Neymotin, Samuel A. |
|
2016 |
|
C |
p. 1-3 3 p. |
artikel |
109 |
Multiscale models of pharmacological, immunological and neurostimulation treatments in Alzheimer's disease
|
Cutsuridis, Vassilis |
|
2016 |
|
C |
p. 85-91 7 p. |
artikel |
110 |
Neural cell cultures to study spinal cord injury
|
McCanney, George A. |
|
2017 |
|
C |
p. 11-20 |
artikel |
111 |
New insights into disorders of basement membranes and integrins of the kidney
|
Pozzi, Ambra |
|
2014 |
|
C |
p. 37-44 8 p. |
artikel |
112 |
Non-human primate models and in vitro liver stage cultures as alternatives in malaria drug development
|
Zeeman, Anne-Marie |
|
2017 |
|
C |
p. 17-23 |
artikel |
113 |
Non-human primate models for disease and human biology: The impact of the Major Histocompatibility Complex
|
Doxiadis, Gaby G.M. |
|
2017 |
|
C |
p. 25-29 |
artikel |
114 |
Non-human primates are essential models in the translational research of multiple sclerosis
|
‘t Hart, Bert A. |
|
2017 |
|
C |
p. 35-42 |
artikel |
115 |
Non-IgE mediated food allergy
|
Lozano-Ojalvo, Daniel |
|
2015 |
|
C |
p. 45-53 9 p. |
artikel |
116 |
Osteoporosis – fracture healing and osseointegration
|
Alghamdi, Hamdan S. |
|
2014 |
|
C |
p. 3-9 7 p. |
artikel |
117 |
Overview of 3Rs opportunities in drug discovery and development using non-human primates
|
Prior, Helen |
|
2017 |
|
C |
p. 11-16 |
artikel |
118 |
Pancreatic islet xenotransplantation
|
Graham, Melanie L. |
|
2017 |
|
C |
p. 43-50 |
artikel |
119 |
Phenotype, endotype and patient-specific computational modelling for optimal treatment design in asthma
|
Donovan, Graham M. |
|
2015 |
|
C |
p. 23-27 5 p. |
artikel |
120 |
Preclinical models of childhood cancer for the development of targeted therapies
|
Kurmasheva, Raushan T. |
|
2016 |
|
C |
p. 3-9 7 p. |
artikel |
121 |
Quantitative morphology of the lung and its importance in investigations of pulmonary diseases in mice
|
Klein, Wilfried |
|
|
|
C |
p. 19-26 |
artikel |
122 |
Recent progress in multi-scale models of the human atria
|
Colman, Michael A. |
|
2014 |
|
C |
p. 23-32 10 p. |
artikel |
123 |
Refinement of the MPTP model for Parkinson’s disease in the marmoset
|
Philippens, Ingrid H.C.H.M |
|
2017 |
|
C |
p. 53-61 |
artikel |
124 |
Reverse engineering the inflammatory “clock”: from computational modeling to rational resetting
|
Vodovotz, Yoram |
|
2016 |
|
C |
p. 57-63 |
artikel |
125 |
Static and dynamic in vitro digestion models to study protein stability in the gastrointestinal tract
|
Dupont, Didier |
|
2015 |
|
C |
p. 23-27 5 p. |
artikel |
126 |
Strange bedfellows: biologists and mathematical modelers tie the knot on cardiomyocyte calcium homeostasis
|
Louch, William E. |
|
2014 |
|
C |
p. 11-16 6 p. |
artikel |
127 |
Systems pharmacology of hepatic metabolism in zebrafish larvae
|
van Wijk, Rob C. |
|
2016 |
|
C |
p. 27-34 |
artikel |
128 |
The African turquoise killifish Nothobranchius furzeri as a model for aging research
|
Reuter, Hanna |
|
2018 |
|
C |
p. 15-22 |
artikel |
129 |
The complexity of Rett syndrome models: Primary fibroblasts as a disease-in-a-dish reliable approach
|
Cordone, Valeria |
|
|
|
C |
p. 11-19 |
artikel |
130 |
The contribution of mouse models in the rare disease alkaptonuria
|
Hughes, Juliette H. |
|
|
|
C |
p. 37-43 |
artikel |
131 |
The epigenomic tool kit
|
Mingay, Matthew |
|
2014 |
|
C |
p. 27-33 7 p. |
artikel |
132 |
The geometric framework: An approach for studying the impact of nutrition on healthy aging
|
Solon-Biet, Samantha M. |
|
2018 |
|
C |
p. 61-68 |
artikel |
133 |
The ME7 prion model of neurodegeneration as a tool to understand and target neuroinflammation in Alzheimer’s disease
|
Chouhan, Joe K. |
|
2017 |
|
C |
p. 45-52 |
artikel |
134 |
The nematode Caenorhabditis elegans as a model for aging research
|
Mack, Hildegard I.D. |
|
2018 |
|
C |
p. 3-13 |
artikel |
135 |
The pharmacological audit trail (PhAT): Use of tumor models to address critical issues in the preclinical development of targeted anticancer drugs
|
Rossanese, Olivia |
|
2016 |
|
C |
p. 23-32 10 p. |
artikel |
136 |
The social honey bee in biomedical research: realities and expectations
|
Maleszka, Ryszard |
|
2014 |
|
C |
p. 7-13 7 p. |
artikel |
137 |
The use of animal models to discover immunological mechanisms underpinning sensitization to food allergens
|
Smit, Joost J. |
|
2015 |
|
C |
p. 63-69 7 p. |
artikel |
138 |
The use of dynamic computational models of neural circuitry to streamline new drug development
|
Arle, Jeffrey E. |
|
2016 |
|
C |
p. 69-75 7 p. |
artikel |
139 |
Tools for exploring mouse models of human disease
|
Haendel, Melissa |
|
2016 |
|
C |
p. 21-26 6 p. |
artikel |
140 |
Towards knowledge-driven cross-species extrapolation
|
Thiel, Christoph |
|
2016 |
|
C |
p. 21-26 |
artikel |
141 |
Tunicates: A model organism to investigate the effects of associated-microbiota on the production of pharmaceuticals
|
Bauermeister, Anelize |
|
|
|
C |
p. 13-20 |
artikel |
142 |
Use and limitations of noninvasive and invasive methods for studying pulmonary function
|
Castro, Juciane Maria de Andrade |
|
|
|
C |
p. 3-9 |
artikel |
143 |
Using gnotobiotic mice to discover and validate therapeutically active microbiota to maintain mucosal homeostasis and treat intestinal inflammation
|
Sartor, R. Balfour |
|
|
|
C |
p. 73-77 |
artikel |
144 |
Using the natural variation of mouse populations to understand host-gut microbiome interactions
|
Org, Elin |
|
|
|
C |
p. 61-71 |
artikel |
145 |
Virtual Brain for neurological disease modeling
|
Bernard, Christophe |
|
2016 |
|
C |
p. 5-10 6 p. |
artikel |
146 |
Virtual liver models in pre-surgical planning, intra-surgical navigation and prognosis analysis
|
Ho, Harvey |
|
2016 |
|
C |
p. 51-56 |
artikel |
147 |
Volatile anesthetics and the treatment of severe bronchospasm: a concept of targeted delivery
|
Mondoñedo, Jarred R. |
|
2015 |
|
C |
p. 43-50 8 p. |
artikel |
148 |
What have we learned so far on the molecular pathogenesis of Werner syndrome using mutant mouse models of this human progeroid disorder?
|
Lebel, Michel |
|
2018 |
|
C |
p. 31-42 |
artikel |
149 |
Wildlife-microbiome interactions and disease: exploring opportunities for disease mitigation across ecological scales
|
Williams, Candace L. |
|
|
|
C |
p. 105-115 |
artikel |
150 |
Without a bug’s life: Germ-free rodents to interrogate microbiota-gut-neuroimmune interactions
|
Spichak, Simon |
|
|
|
C |
p. 79-93 |
artikel |